nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—VEGFA—Alzheimer's disease	0.223	0.53	CbGaD
Carvedilol—PTGS1—Alzheimer's disease	0.118	0.28	CbGaD
Carvedilol—CYP2D6—Alzheimer's disease	0.0801	0.19	CbGaD
Carvedilol—CYP2D6—Rivastigmine—Alzheimer's disease	0.0416	0.215	CbGbCtD
Carvedilol—CYP2C9—Donepezil—Alzheimer's disease	0.0364	0.188	CbGbCtD
Carvedilol—CYP2D6—Donepezil—Alzheimer's disease	0.0333	0.172	CbGbCtD
Carvedilol—CYP3A4—Rivastigmine—Alzheimer's disease	0.0265	0.136	CbGbCtD
Carvedilol—CYP2D6—Galantamine—Alzheimer's disease	0.0214	0.111	CbGbCtD
Carvedilol—CYP3A4—Donepezil—Alzheimer's disease	0.0211	0.109	CbGbCtD
Carvedilol—CYP3A4—Galantamine—Alzheimer's disease	0.0136	0.0703	CbGbCtD
Carvedilol—NPPB—blood vessel—Alzheimer's disease	0.00487	0.0733	CbGeAlD
Carvedilol—GJA1—Tetrabenazine—Donepezil—Alzheimer's disease	0.00407	1	CbGdCrCtD
Carvedilol—SELE—blood vessel—Alzheimer's disease	0.00329	0.0495	CbGeAlD
Carvedilol—VCAM1—blood vessel—Alzheimer's disease	0.00302	0.0456	CbGeAlD
Carvedilol—HIF1A—blood vessel—Alzheimer's disease	0.00291	0.0438	CbGeAlD
Carvedilol—GJA1—blood vessel—Alzheimer's disease	0.00282	0.0425	CbGeAlD
Carvedilol—HIF1A—embryo—Alzheimer's disease	0.00173	0.0262	CbGeAlD
Carvedilol—GJA1—embryo—Alzheimer's disease	0.00168	0.0254	CbGeAlD
Carvedilol—HIF1A—forebrain—Alzheimer's disease	0.00153	0.0231	CbGeAlD
Carvedilol—GJA1—forebrain—Alzheimer's disease	0.00149	0.0224	CbGeAlD
Carvedilol—HIF1A—telencephalon—Alzheimer's disease	0.00141	0.0213	CbGeAlD
Carvedilol—NPPB—nervous system—Alzheimer's disease	0.00139	0.021	CbGeAlD
Carvedilol—GJA1—telencephalon—Alzheimer's disease	0.00137	0.0206	CbGeAlD
Carvedilol—NPPB—central nervous system—Alzheimer's disease	0.00134	0.0202	CbGeAlD
Carvedilol—NDUFC2—forebrain—Alzheimer's disease	0.0013	0.0195	CbGeAlD
Carvedilol—NDUFC2—telencephalon—Alzheimer's disease	0.00119	0.018	CbGeAlD
Carvedilol—VEGFA—telencephalon—Alzheimer's disease	0.00108	0.0163	CbGeAlD
Carvedilol—NPPB—brain—Alzheimer's disease	0.00107	0.0161	CbGeAlD
Carvedilol—SELE—nervous system—Alzheimer's disease	0.000941	0.0142	CbGeAlD
Carvedilol—SELE—central nervous system—Alzheimer's disease	0.000906	0.0137	CbGeAlD
Carvedilol—SELE—cerebellum—Alzheimer's disease	0.000886	0.0134	CbGeAlD
Carvedilol—VCAM1—nervous system—Alzheimer's disease	0.000866	0.0131	CbGeAlD
Carvedilol—VCAM1—central nervous system—Alzheimer's disease	0.000834	0.0126	CbGeAlD
Carvedilol—HIF1A—nervous system—Alzheimer's disease	0.000833	0.0126	CbGeAlD
Carvedilol—GJA1—nervous system—Alzheimer's disease	0.000808	0.0122	CbGeAlD
Carvedilol—HIF1A—central nervous system—Alzheimer's disease	0.000802	0.0121	CbGeAlD
Carvedilol—HIF1A—cerebellum—Alzheimer's disease	0.000784	0.0118	CbGeAlD
Carvedilol—GJA1—central nervous system—Alzheimer's disease	0.000778	0.0117	CbGeAlD
Carvedilol—ADRA1D—forebrain—Alzheimer's disease	0.000768	0.0116	CbGeAlD
Carvedilol—GJA1—cerebellum—Alzheimer's disease	0.00076	0.0115	CbGeAlD
Carvedilol—SELE—brain—Alzheimer's disease	0.000719	0.0108	CbGeAlD
Carvedilol—ADRA1D—telencephalon—Alzheimer's disease	0.000706	0.0106	CbGeAlD
Carvedilol—NDUFC2—nervous system—Alzheimer's disease	0.000703	0.0106	CbGeAlD
Carvedilol—NDUFC2—central nervous system—Alzheimer's disease	0.000677	0.0102	CbGeAlD
Carvedilol—NDUFC2—cerebellum—Alzheimer's disease	0.000662	0.00998	CbGeAlD
Carvedilol—VCAM1—brain—Alzheimer's disease	0.000662	0.00998	CbGeAlD
Carvedilol—HIF1A—brain—Alzheimer's disease	0.000637	0.0096	CbGeAlD
Carvedilol—GJA1—brain—Alzheimer's disease	0.000618	0.00931	CbGeAlD
Carvedilol—VEGFA—cerebellum—Alzheimer's disease	0.0006	0.00905	CbGeAlD
Carvedilol—PTGS1—blood vessel—Alzheimer's disease	0.000599	0.00903	CbGeAlD
Carvedilol—ADRB1—forebrain—Alzheimer's disease	0.000558	0.00841	CbGeAlD
Carvedilol—NDUFC2—brain—Alzheimer's disease	0.000538	0.0081	CbGeAlD
Carvedilol—ADRB1—telencephalon—Alzheimer's disease	0.000513	0.00773	CbGeAlD
Carvedilol—VEGFA—brain—Alzheimer's disease	0.000488	0.00735	CbGeAlD
Carvedilol—ADRA1A—forebrain—Alzheimer's disease	0.000441	0.00665	CbGeAlD
Carvedilol—ADRA1B—nervous system—Alzheimer's disease	0.000426	0.00642	CbGeAlD
Carvedilol—KCNH2—forebrain—Alzheimer's disease	0.000426	0.00642	CbGeAlD
Carvedilol—ADRA1D—nervous system—Alzheimer's disease	0.000417	0.00628	CbGeAlD
Carvedilol—ADRA1B—central nervous system—Alzheimer's disease	0.00041	0.00618	CbGeAlD
Carvedilol—ADRA1A—telencephalon—Alzheimer's disease	0.000406	0.00611	CbGeAlD
Carvedilol—ADRA1D—central nervous system—Alzheimer's disease	0.000401	0.00605	CbGeAlD
Carvedilol—KCNH2—telencephalon—Alzheimer's disease	0.000392	0.0059	CbGeAlD
Carvedilol—ADRA2C—telencephalon—Alzheimer's disease	0.000386	0.00582	CbGeAlD
Carvedilol—ABCB1—blood vessel—Alzheimer's disease	0.000354	0.00534	CbGeAlD
Carvedilol—ADRA2A—forebrain—Alzheimer's disease	0.000335	0.00505	CbGeAlD
Carvedilol—ADRA1B—brain—Alzheimer's disease	0.000326	0.00491	CbGeAlD
Carvedilol—ADRA1D—brain—Alzheimer's disease	0.000319	0.0048	CbGeAlD
Carvedilol—PTGS1—forebrain—Alzheimer's disease	0.000316	0.00476	CbGeAlD
Carvedilol—ADRA2A—telencephalon—Alzheimer's disease	0.000308	0.00465	CbGeAlD
Carvedilol—ADRB1—nervous system—Alzheimer's disease	0.000303	0.00456	CbGeAlD
Carvedilol—CYP2E1—telencephalon—Alzheimer's disease	0.000302	0.00455	CbGeAlD
Carvedilol—ADRB1—central nervous system—Alzheimer's disease	0.000292	0.00439	CbGeAlD
Carvedilol—PTGS1—telencephalon—Alzheimer's disease	0.000291	0.00438	CbGeAlD
Carvedilol—Ranolazine—CYP2D6—Alzheimer's disease	0.000285	0.347	CrCbGaD
Carvedilol—Tamsulosin—CYP2D6—Alzheimer's disease	0.000274	0.334	CrCbGaD
Carvedilol—CYP2D6—forebrain—Alzheimer's disease	0.00026	0.00392	CbGeAlD
Carvedilol—ADRA1A—nervous system—Alzheimer's disease	0.000239	0.00361	CbGeAlD
Carvedilol—CYP2D6—telencephalon—Alzheimer's disease	0.000239	0.0036	CbGeAlD
Carvedilol—ADRB1—brain—Alzheimer's disease	0.000231	0.00349	CbGeAlD
Carvedilol—KCNH2—nervous system—Alzheimer's disease	0.000231	0.00349	CbGeAlD
Carvedilol—ADRA1A—central nervous system—Alzheimer's disease	0.000231	0.00347	CbGeAlD
Carvedilol—ADRA2C—nervous system—Alzheimer's disease	0.000228	0.00344	CbGeAlD
Carvedilol—ADRA1A—cerebellum—Alzheimer's disease	0.000225	0.0034	CbGeAlD
Carvedilol—KCNH2—central nervous system—Alzheimer's disease	0.000223	0.00336	CbGeAlD
Carvedilol—ADRA2C—central nervous system—Alzheimer's disease	0.00022	0.00331	CbGeAlD
Carvedilol—KCNH2—cerebellum—Alzheimer's disease	0.000218	0.00328	CbGeAlD
Carvedilol—Renal failure—Rivastigmine—Alzheimer's disease	0.000216	0.00117	CcSEcCtD
Carvedilol—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000215	0.00117	CcSEcCtD
Carvedilol—Hypertension—Galantamine—Alzheimer's disease	0.000215	0.00117	CcSEcCtD
Carvedilol—ADRA2C—cerebellum—Alzheimer's disease	0.000215	0.00324	CbGeAlD
Carvedilol—Haematuria—Memantine—Alzheimer's disease	0.000214	0.00116	CcSEcCtD
Carvedilol—Visual impairment—Donepezil—Alzheimer's disease	0.000214	0.00116	CcSEcCtD
Carvedilol—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000213	0.00116	CcSEcCtD
Carvedilol—Arthralgia—Galantamine—Alzheimer's disease	0.000212	0.00115	CcSEcCtD
Carvedilol—Myalgia—Galantamine—Alzheimer's disease	0.000212	0.00115	CcSEcCtD
Carvedilol—Chest pain—Galantamine—Alzheimer's disease	0.000212	0.00115	CcSEcCtD
Carvedilol—ABCB1—embryo—Alzheimer's disease	0.000211	0.00318	CbGeAlD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000211	0.00114	CcSEcCtD
Carvedilol—Sinusitis—Memantine—Alzheimer's disease	0.00021	0.00114	CcSEcCtD
Carvedilol—Discomfort—Galantamine—Alzheimer's disease	0.00021	0.00114	CcSEcCtD
Carvedilol—Haematuria—Rivastigmine—Alzheimer's disease	0.000209	0.00114	CcSEcCtD
Carvedilol—Dry mouth—Galantamine—Alzheimer's disease	0.000207	0.00113	CcSEcCtD
Carvedilol—Tinnitus—Donepezil—Alzheimer's disease	0.000207	0.00112	CcSEcCtD
Carvedilol—Sinusitis—Rivastigmine—Alzheimer's disease	0.000206	0.00112	CcSEcCtD
Carvedilol—Confusional state—Galantamine—Alzheimer's disease	0.000205	0.00111	CcSEcCtD
Carvedilol—Bradycardia—Memantine—Alzheimer's disease	0.000205	0.00111	CcSEcCtD
Carvedilol—Haemoglobin—Memantine—Alzheimer's disease	0.000202	0.0011	CcSEcCtD
Carvedilol—Rhinitis—Memantine—Alzheimer's disease	0.000202	0.0011	CcSEcCtD
Carvedilol—Haemorrhage—Memantine—Alzheimer's disease	0.000201	0.00109	CcSEcCtD
Carvedilol—Bradycardia—Rivastigmine—Alzheimer's disease	0.000201	0.00109	CcSEcCtD
Carvedilol—Hypoaesthesia—Memantine—Alzheimer's disease	0.0002	0.00109	CcSEcCtD
Carvedilol—Shock—Galantamine—Alzheimer's disease	0.0002	0.00109	CcSEcCtD
Carvedilol—Pharyngitis—Memantine—Alzheimer's disease	0.0002	0.00109	CcSEcCtD
Carvedilol—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000199	0.00108	CcSEcCtD
Carvedilol—Urinary tract disorder—Memantine—Alzheimer's disease	0.000199	0.00108	CcSEcCtD
Carvedilol—Tachycardia—Galantamine—Alzheimer's disease	0.000198	0.00108	CcSEcCtD
Carvedilol—Oedema peripheral—Memantine—Alzheimer's disease	0.000198	0.00108	CcSEcCtD
Carvedilol—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000198	0.00108	CcSEcCtD
Carvedilol—Rhinitis—Rivastigmine—Alzheimer's disease	0.000197	0.00107	CcSEcCtD
Carvedilol—Skin disorder—Galantamine—Alzheimer's disease	0.000197	0.00107	CcSEcCtD
Carvedilol—Urethral disorder—Memantine—Alzheimer's disease	0.000197	0.00107	CcSEcCtD
Carvedilol—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000197	0.00107	CcSEcCtD
Carvedilol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000197	0.00107	CcSEcCtD
Carvedilol—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000196	0.00107	CcSEcCtD
Carvedilol—Alopecia—Donepezil—Alzheimer's disease	0.000196	0.00106	CcSEcCtD
Carvedilol—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000196	0.00106	CcSEcCtD
Carvedilol—CYP1A1—nervous system—Alzheimer's disease	0.000195	0.00294	CbGeAlD
Carvedilol—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000195	0.00106	CcSEcCtD
Carvedilol—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000194	0.00105	CcSEcCtD
Carvedilol—Visual impairment—Memantine—Alzheimer's disease	0.000194	0.00105	CcSEcCtD
Carvedilol—Anorexia—Galantamine—Alzheimer's disease	0.000194	0.00105	CcSEcCtD
Carvedilol—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000193	0.00105	CcSEcCtD
Carvedilol—Malnutrition—Donepezil—Alzheimer's disease	0.000193	0.00105	CcSEcCtD
Carvedilol—Erythema multiforme—Memantine—Alzheimer's disease	0.00019	0.00103	CcSEcCtD
Carvedilol—Flatulence—Donepezil—Alzheimer's disease	0.00019	0.00103	CcSEcCtD
Carvedilol—Hypotension—Galantamine—Alzheimer's disease	0.00019	0.00103	CcSEcCtD
Carvedilol—Visual impairment—Rivastigmine—Alzheimer's disease	0.00019	0.00103	CcSEcCtD
Carvedilol—Tension—Donepezil—Alzheimer's disease	0.000189	0.00103	CcSEcCtD
Carvedilol—CYP1A1—central nervous system—Alzheimer's disease	0.000188	0.00283	CbGeAlD
Carvedilol—Tinnitus—Memantine—Alzheimer's disease	0.000188	0.00102	CcSEcCtD
Carvedilol—Nervousness—Donepezil—Alzheimer's disease	0.000188	0.00102	CcSEcCtD
Carvedilol—ABCB1—forebrain—Alzheimer's disease	0.000187	0.00282	CbGeAlD
Carvedilol—Back pain—Donepezil—Alzheimer's disease	0.000187	0.00101	CcSEcCtD
Carvedilol—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000186	0.00101	CcSEcCtD
Carvedilol—Muscle spasms—Donepezil—Alzheimer's disease	0.000186	0.00101	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000185	0.00101	CcSEcCtD
Carvedilol—Insomnia—Galantamine—Alzheimer's disease	0.000184	0.000999	CcSEcCtD
Carvedilol—Tinnitus—Rivastigmine—Alzheimer's disease	0.000184	0.000998	CcSEcCtD
Carvedilol—ADRA1A—brain—Alzheimer's disease	0.000183	0.00276	CbGeAlD
Carvedilol—Angiopathy—Memantine—Alzheimer's disease	0.000183	0.000993	CcSEcCtD
Carvedilol—Paraesthesia—Galantamine—Alzheimer's disease	0.000183	0.000992	CcSEcCtD
Carvedilol—ADRA2A—nervous system—Alzheimer's disease	0.000182	0.00274	CbGeAlD
Carvedilol—Vision blurred—Donepezil—Alzheimer's disease	0.000182	0.000989	CcSEcCtD
Carvedilol—Immune system disorder—Memantine—Alzheimer's disease	0.000182	0.000988	CcSEcCtD
Carvedilol—Mediastinal disorder—Memantine—Alzheimer's disease	0.000181	0.000986	CcSEcCtD
Carvedilol—Somnolence—Galantamine—Alzheimer's disease	0.000181	0.000982	CcSEcCtD
Carvedilol—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000179	0.000973	CcSEcCtD
Carvedilol—Dyspepsia—Galantamine—Alzheimer's disease	0.000179	0.000973	CcSEcCtD
Carvedilol—Angiopathy—Rivastigmine—Alzheimer's disease	0.000179	0.000971	CcSEcCtD
Carvedilol—Anaemia—Donepezil—Alzheimer's disease	0.000178	0.00097	CcSEcCtD
Carvedilol—CYP2E1—nervous system—Alzheimer's disease	0.000178	0.00268	CbGeAlD
Carvedilol—Alopecia—Memantine—Alzheimer's disease	0.000178	0.000967	CcSEcCtD
Carvedilol—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000178	0.000965	CcSEcCtD
Carvedilol—KCNH2—brain—Alzheimer's disease	0.000177	0.00266	CbGeAlD
Carvedilol—Decreased appetite—Galantamine—Alzheimer's disease	0.000177	0.00096	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000176	0.000954	CcSEcCtD
Carvedilol—Malnutrition—Memantine—Alzheimer's disease	0.000175	0.000953	CcSEcCtD
Carvedilol—Fatigue—Galantamine—Alzheimer's disease	0.000175	0.000953	CcSEcCtD
Carvedilol—ADRA2A—central nervous system—Alzheimer's disease	0.000175	0.00264	CbGeAlD
Carvedilol—ADRA2C—brain—Alzheimer's disease	0.000174	0.00263	CbGeAlD
Carvedilol—Malaise—Donepezil—Alzheimer's disease	0.000174	0.000946	CcSEcCtD
Carvedilol—Alopecia—Rivastigmine—Alzheimer's disease	0.000174	0.000946	CcSEcCtD
Carvedilol—Constipation—Galantamine—Alzheimer's disease	0.000174	0.000945	CcSEcCtD
Carvedilol—Vertigo—Donepezil—Alzheimer's disease	0.000173	0.000943	CcSEcCtD
Carvedilol—Syncope—Donepezil—Alzheimer's disease	0.000173	0.000941	CcSEcCtD
Carvedilol—Flatulence—Memantine—Alzheimer's disease	0.000173	0.000939	CcSEcCtD
Carvedilol—Tension—Memantine—Alzheimer's disease	0.000172	0.000935	CcSEcCtD
Carvedilol—ABCB1—telencephalon—Alzheimer's disease	0.000172	0.00259	CbGeAlD
Carvedilol—PTGS1—nervous system—Alzheimer's disease	0.000172	0.00259	CbGeAlD
Carvedilol—Malnutrition—Rivastigmine—Alzheimer's disease	0.000171	0.000932	CcSEcCtD
Carvedilol—CYP2E1—central nervous system—Alzheimer's disease	0.000171	0.00258	CbGeAlD
Carvedilol—ADRA2A—cerebellum—Alzheimer's disease	0.000171	0.00258	CbGeAlD
Carvedilol—Nervousness—Memantine—Alzheimer's disease	0.00017	0.000925	CcSEcCtD
Carvedilol—Loss of consciousness—Donepezil—Alzheimer's disease	0.00017	0.000922	CcSEcCtD
Carvedilol—Back pain—Memantine—Alzheimer's disease	0.00017	0.000921	CcSEcCtD
Carvedilol—Flatulence—Rivastigmine—Alzheimer's disease	0.000169	0.000918	CcSEcCtD
Carvedilol—Cough—Donepezil—Alzheimer's disease	0.000168	0.000915	CcSEcCtD
Carvedilol—Tension—Rivastigmine—Alzheimer's disease	0.000168	0.000914	CcSEcCtD
Carvedilol—CYP2E1—cerebellum—Alzheimer's disease	0.000168	0.00253	CbGeAlD
Carvedilol—Feeling abnormal—Galantamine—Alzheimer's disease	0.000168	0.00091	CcSEcCtD
Carvedilol—Convulsion—Donepezil—Alzheimer's disease	0.000167	0.000909	CcSEcCtD
Carvedilol—Hypertension—Donepezil—Alzheimer's disease	0.000167	0.000906	CcSEcCtD
Carvedilol—Nervousness—Rivastigmine—Alzheimer's disease	0.000167	0.000905	CcSEcCtD
Carvedilol—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000166	0.000903	CcSEcCtD
Carvedilol—Back pain—Rivastigmine—Alzheimer's disease	0.000166	0.000901	CcSEcCtD
Carvedilol—Vision blurred—Memantine—Alzheimer's disease	0.000165	0.000898	CcSEcCtD
Carvedilol—PTGS1—central nervous system—Alzheimer's disease	0.000165	0.00249	CbGeAlD
Carvedilol—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000165	0.000896	CcSEcCtD
Carvedilol—Myalgia—Donepezil—Alzheimer's disease	0.000164	0.000893	CcSEcCtD
Carvedilol—Chest pain—Donepezil—Alzheimer's disease	0.000164	0.000893	CcSEcCtD
Carvedilol—Arthralgia—Donepezil—Alzheimer's disease	0.000164	0.000893	CcSEcCtD
Carvedilol—Ill-defined disorder—Memantine—Alzheimer's disease	0.000163	0.000884	CcSEcCtD
Carvedilol—Discomfort—Donepezil—Alzheimer's disease	0.000162	0.000882	CcSEcCtD
Carvedilol—Anaemia—Memantine—Alzheimer's disease	0.000162	0.00088	CcSEcCtD
Carvedilol—Vision blurred—Rivastigmine—Alzheimer's disease	0.000162	0.000878	CcSEcCtD
Carvedilol—Dry mouth—Donepezil—Alzheimer's disease	0.000161	0.000874	CcSEcCtD
Carvedilol—Abdominal pain—Galantamine—Alzheimer's disease	0.000161	0.000873	CcSEcCtD
Carvedilol—Body temperature increased—Galantamine—Alzheimer's disease	0.000161	0.000873	CcSEcCtD
Carvedilol—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000159	0.000865	CcSEcCtD
Carvedilol—Confusional state—Donepezil—Alzheimer's disease	0.000159	0.000863	CcSEcCtD
Carvedilol—Anaemia—Rivastigmine—Alzheimer's disease	0.000158	0.000861	CcSEcCtD
Carvedilol—Malaise—Memantine—Alzheimer's disease	0.000158	0.000859	CcSEcCtD
Carvedilol—Oedema—Donepezil—Alzheimer's disease	0.000158	0.000856	CcSEcCtD
Carvedilol—Vertigo—Memantine—Alzheimer's disease	0.000157	0.000856	CcSEcCtD
Carvedilol—Syncope—Memantine—Alzheimer's disease	0.000157	0.000854	CcSEcCtD
Carvedilol—Leukopenia—Memantine—Alzheimer's disease	0.000157	0.000853	CcSEcCtD
Carvedilol—Infection—Donepezil—Alzheimer's disease	0.000157	0.000851	CcSEcCtD
Carvedilol—Propafenone—CYP2D6—Alzheimer's disease	0.000156	0.19	CrCbGaD
Carvedilol—Shock—Donepezil—Alzheimer's disease	0.000155	0.000842	CcSEcCtD
Carvedilol—Palpitations—Memantine—Alzheimer's disease	0.000155	0.000842	CcSEcCtD
Carvedilol—Malaise—Rivastigmine—Alzheimer's disease	0.000155	0.00084	CcSEcCtD
Carvedilol—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000154	0.000838	CcSEcCtD
Carvedilol—Vertigo—Rivastigmine—Alzheimer's disease	0.000154	0.000837	CcSEcCtD
Carvedilol—Loss of consciousness—Memantine—Alzheimer's disease	0.000154	0.000837	CcSEcCtD
Carvedilol—Syncope—Rivastigmine—Alzheimer's disease	0.000154	0.000836	CcSEcCtD
Carvedilol—Cough—Memantine—Alzheimer's disease	0.000153	0.000831	CcSEcCtD
Carvedilol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000152	0.000828	CcSEcCtD
Carvedilol—Convulsion—Memantine—Alzheimer's disease	0.000152	0.000825	CcSEcCtD
Carvedilol—Palpitations—Rivastigmine—Alzheimer's disease	0.000152	0.000824	CcSEcCtD
Carvedilol—Hypertension—Memantine—Alzheimer's disease	0.000151	0.000822	CcSEcCtD
Carvedilol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000151	0.000819	CcSEcCtD
Carvedilol—Anorexia—Donepezil—Alzheimer's disease	0.00015	0.000816	CcSEcCtD
Carvedilol—Hypersensitivity—Galantamine—Alzheimer's disease	0.00015	0.000814	CcSEcCtD
Carvedilol—Cough—Rivastigmine—Alzheimer's disease	0.00015	0.000813	CcSEcCtD
Carvedilol—CYP1A1—brain—Alzheimer's disease	0.000149	0.00225	CbGeAlD
Carvedilol—Myalgia—Memantine—Alzheimer's disease	0.000149	0.000811	CcSEcCtD
Carvedilol—Arthralgia—Memantine—Alzheimer's disease	0.000149	0.000811	CcSEcCtD
Carvedilol—Chest pain—Memantine—Alzheimer's disease	0.000149	0.000811	CcSEcCtD
Carvedilol—Convulsion—Rivastigmine—Alzheimer's disease	0.000149	0.000807	CcSEcCtD
Carvedilol—Hypertension—Rivastigmine—Alzheimer's disease	0.000148	0.000805	CcSEcCtD
Carvedilol—Discomfort—Memantine—Alzheimer's disease	0.000147	0.000801	CcSEcCtD
Carvedilol—Hypotension—Donepezil—Alzheimer's disease	0.000147	0.0008	CcSEcCtD
Carvedilol—Chest pain—Rivastigmine—Alzheimer's disease	0.000146	0.000793	CcSEcCtD
Carvedilol—Myalgia—Rivastigmine—Alzheimer's disease	0.000146	0.000793	CcSEcCtD
Carvedilol—Arthralgia—Rivastigmine—Alzheimer's disease	0.000146	0.000793	CcSEcCtD
Carvedilol—Dry mouth—Memantine—Alzheimer's disease	0.000146	0.000793	CcSEcCtD
Carvedilol—Asthenia—Galantamine—Alzheimer's disease	0.000146	0.000793	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000145	0.000788	CcSEcCtD
Carvedilol—Confusional state—Memantine—Alzheimer's disease	0.000144	0.000784	CcSEcCtD
Carvedilol—Discomfort—Rivastigmine—Alzheimer's disease	0.000144	0.000784	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000144	0.00078	CcSEcCtD
Carvedilol—CYP3A4—nervous system—Alzheimer's disease	0.000143	0.00216	CbGeAlD
Carvedilol—Oedema—Memantine—Alzheimer's disease	0.000143	0.000777	CcSEcCtD
Carvedilol—Dry mouth—Rivastigmine—Alzheimer's disease	0.000143	0.000776	CcSEcCtD
Carvedilol—Insomnia—Donepezil—Alzheimer's disease	0.000143	0.000774	CcSEcCtD
Carvedilol—Infection—Memantine—Alzheimer's disease	0.000142	0.000772	CcSEcCtD
Carvedilol—Paraesthesia—Donepezil—Alzheimer's disease	0.000141	0.000769	CcSEcCtD
Carvedilol—Confusional state—Rivastigmine—Alzheimer's disease	0.000141	0.000767	CcSEcCtD
Carvedilol—CYP2D6—nervous system—Alzheimer's disease	0.000141	0.00213	CbGeAlD
Carvedilol—Shock—Memantine—Alzheimer's disease	0.000141	0.000765	CcSEcCtD
Carvedilol—Dyspnoea—Donepezil—Alzheimer's disease	0.00014	0.000763	CcSEcCtD
Carvedilol—Somnolence—Donepezil—Alzheimer's disease	0.00014	0.000761	CcSEcCtD
Carvedilol—Thrombocytopenia—Memantine—Alzheimer's disease	0.00014	0.000761	CcSEcCtD
Carvedilol—Oedema—Rivastigmine—Alzheimer's disease	0.00014	0.000761	CcSEcCtD
Carvedilol—Tachycardia—Memantine—Alzheimer's disease	0.00014	0.000759	CcSEcCtD
Carvedilol—ADRA2A—brain—Alzheimer's disease	0.000139	0.0021	CbGeAlD
Carvedilol—Diarrhoea—Galantamine—Alzheimer's disease	0.000139	0.000756	CcSEcCtD
Carvedilol—Infection—Rivastigmine—Alzheimer's disease	0.000139	0.000756	CcSEcCtD
Carvedilol—Skin disorder—Memantine—Alzheimer's disease	0.000139	0.000755	CcSEcCtD
Carvedilol—Dyspepsia—Donepezil—Alzheimer's disease	0.000139	0.000754	CcSEcCtD
Carvedilol—Hyperhidrosis—Memantine—Alzheimer's disease	0.000138	0.000752	CcSEcCtD
Carvedilol—CYP3A4—central nervous system—Alzheimer's disease	0.000138	0.00208	CbGeAlD
Carvedilol—Shock—Rivastigmine—Alzheimer's disease	0.000138	0.000748	CcSEcCtD
Carvedilol—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000137	0.000745	CcSEcCtD
Carvedilol—Decreased appetite—Donepezil—Alzheimer's disease	0.000137	0.000744	CcSEcCtD
Carvedilol—Tachycardia—Rivastigmine—Alzheimer's disease	0.000137	0.000742	CcSEcCtD
Carvedilol—Anorexia—Memantine—Alzheimer's disease	0.000136	0.000741	CcSEcCtD
Carvedilol—CYP2E1—brain—Alzheimer's disease	0.000136	0.00205	CbGeAlD
Carvedilol—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000136	0.000739	CcSEcCtD
Carvedilol—Skin disorder—Rivastigmine—Alzheimer's disease	0.000136	0.000739	CcSEcCtD
Carvedilol—Fatigue—Donepezil—Alzheimer's disease	0.000136	0.000738	CcSEcCtD
Carvedilol—CYP2D6—central nervous system—Alzheimer's disease	0.000136	0.00205	CbGeAlD
Carvedilol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000135	0.000735	CcSEcCtD
Carvedilol—Constipation—Donepezil—Alzheimer's disease	0.000135	0.000732	CcSEcCtD
Carvedilol—Pain—Donepezil—Alzheimer's disease	0.000135	0.000732	CcSEcCtD
Carvedilol—Dizziness—Galantamine—Alzheimer's disease	0.000134	0.000731	CcSEcCtD
Carvedilol—Hypotension—Memantine—Alzheimer's disease	0.000134	0.000726	CcSEcCtD
Carvedilol—Anorexia—Rivastigmine—Alzheimer's disease	0.000133	0.000725	CcSEcCtD
Carvedilol—CYP2D6—cerebellum—Alzheimer's disease	0.000133	0.002	CbGeAlD
Carvedilol—PTGS1—brain—Alzheimer's disease	0.000131	0.00198	CbGeAlD
Carvedilol—Hypotension—Rivastigmine—Alzheimer's disease	0.000131	0.000711	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00013	0.000708	CcSEcCtD
Carvedilol—Feeling abnormal—Donepezil—Alzheimer's disease	0.00013	0.000706	CcSEcCtD
Carvedilol—Insomnia—Memantine—Alzheimer's disease	0.000129	0.000703	CcSEcCtD
Carvedilol—Vomiting—Galantamine—Alzheimer's disease	0.000129	0.000702	CcSEcCtD
Carvedilol—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000129	0.0007	CcSEcCtD
Carvedilol—Paraesthesia—Memantine—Alzheimer's disease	0.000128	0.000698	CcSEcCtD
Carvedilol—Rash—Galantamine—Alzheimer's disease	0.000128	0.000697	CcSEcCtD
Carvedilol—Dermatitis—Galantamine—Alzheimer's disease	0.000128	0.000696	CcSEcCtD
Carvedilol—Dyspnoea—Memantine—Alzheimer's disease	0.000128	0.000693	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000128	0.000693	CcSEcCtD
Carvedilol—Headache—Galantamine—Alzheimer's disease	0.000127	0.000692	CcSEcCtD
Carvedilol—Somnolence—Memantine—Alzheimer's disease	0.000127	0.000691	CcSEcCtD
Carvedilol—Insomnia—Rivastigmine—Alzheimer's disease	0.000127	0.000688	CcSEcCtD
Carvedilol—Dyspepsia—Memantine—Alzheimer's disease	0.000126	0.000684	CcSEcCtD
Carvedilol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000126	0.000683	CcSEcCtD
Carvedilol—Urticaria—Donepezil—Alzheimer's disease	0.000125	0.00068	CcSEcCtD
Carvedilol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000125	0.000678	CcSEcCtD
Carvedilol—Abdominal pain—Donepezil—Alzheimer's disease	0.000125	0.000677	CcSEcCtD
Carvedilol—Body temperature increased—Donepezil—Alzheimer's disease	0.000125	0.000677	CcSEcCtD
Carvedilol—Somnolence—Rivastigmine—Alzheimer's disease	0.000124	0.000676	CcSEcCtD
Carvedilol—Decreased appetite—Memantine—Alzheimer's disease	0.000124	0.000676	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000124	0.000671	CcSEcCtD
Carvedilol—Fatigue—Memantine—Alzheimer's disease	0.000123	0.00067	CcSEcCtD
Carvedilol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000123	0.000669	CcSEcCtD
Carvedilol—Constipation—Memantine—Alzheimer's disease	0.000122	0.000665	CcSEcCtD
Carvedilol—Pain—Memantine—Alzheimer's disease	0.000122	0.000665	CcSEcCtD
Carvedilol—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000122	0.000661	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000121	0.000657	CcSEcCtD
Carvedilol—Nausea—Galantamine—Alzheimer's disease	0.000121	0.000656	CcSEcCtD
Carvedilol—Fatigue—Rivastigmine—Alzheimer's disease	0.000121	0.000656	CcSEcCtD
Carvedilol—Pain—Rivastigmine—Alzheimer's disease	0.00012	0.00065	CcSEcCtD
Carvedilol—Constipation—Rivastigmine—Alzheimer's disease	0.00012	0.00065	CcSEcCtD
Carvedilol—Feeling abnormal—Memantine—Alzheimer's disease	0.000118	0.000641	CcSEcCtD
Carvedilol—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000117	0.000636	CcSEcCtD
Carvedilol—Hypersensitivity—Donepezil—Alzheimer's disease	0.000116	0.000631	CcSEcCtD
Carvedilol—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000115	0.000627	CcSEcCtD
Carvedilol—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000114	0.000622	CcSEcCtD
Carvedilol—Urticaria—Memantine—Alzheimer's disease	0.000114	0.000618	CcSEcCtD
Carvedilol—Abdominal pain—Memantine—Alzheimer's disease	0.000113	0.000615	CcSEcCtD
Carvedilol—Body temperature increased—Memantine—Alzheimer's disease	0.000113	0.000615	CcSEcCtD
Carvedilol—Asthenia—Donepezil—Alzheimer's disease	0.000113	0.000614	CcSEcCtD
Carvedilol—Pruritus—Donepezil—Alzheimer's disease	0.000111	0.000606	CcSEcCtD
Carvedilol—Urticaria—Rivastigmine—Alzheimer's disease	0.000111	0.000604	CcSEcCtD
Carvedilol—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000111	0.000601	CcSEcCtD
Carvedilol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000111	0.000601	CcSEcCtD
Carvedilol—Diarrhoea—Donepezil—Alzheimer's disease	0.000108	0.000586	CcSEcCtD
Carvedilol—CYP2D6—brain—Alzheimer's disease	0.000108	0.00162	CbGeAlD
Carvedilol—Propranolol—CYP2D6—Alzheimer's disease	0.000107	0.13	CrCbGaD
Carvedilol—Hypersensitivity—Memantine—Alzheimer's disease	0.000105	0.000573	CcSEcCtD
Carvedilol—Dizziness—Donepezil—Alzheimer's disease	0.000104	0.000566	CcSEcCtD
Carvedilol—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000103	0.00056	CcSEcCtD
Carvedilol—Asthenia—Memantine—Alzheimer's disease	0.000103	0.000558	CcSEcCtD
Carvedilol—ABCB1—nervous system—Alzheimer's disease	0.000101	0.00153	CbGeAlD
Carvedilol—Pruritus—Memantine—Alzheimer's disease	0.000101	0.00055	CcSEcCtD
Carvedilol—Asthenia—Rivastigmine—Alzheimer's disease	0.0001	0.000546	CcSEcCtD
Carvedilol—Vomiting—Donepezil—Alzheimer's disease	0.0001	0.000544	CcSEcCtD
Carvedilol—Rash—Donepezil—Alzheimer's disease	9.93e-05	0.00054	CcSEcCtD
Carvedilol—Dermatitis—Donepezil—Alzheimer's disease	9.93e-05	0.000539	CcSEcCtD
Carvedilol—Pruritus—Rivastigmine—Alzheimer's disease	9.9e-05	0.000538	CcSEcCtD
Carvedilol—Headache—Donepezil—Alzheimer's disease	9.87e-05	0.000536	CcSEcCtD
Carvedilol—Diarrhoea—Memantine—Alzheimer's disease	9.79e-05	0.000532	CcSEcCtD
Carvedilol—ABCB1—central nervous system—Alzheimer's disease	9.77e-05	0.00147	CbGeAlD
Carvedilol—Diarrhoea—Rivastigmine—Alzheimer's disease	9.58e-05	0.00052	CcSEcCtD
Carvedilol—ABCB1—cerebellum—Alzheimer's disease	9.55e-05	0.00144	CbGeAlD
Carvedilol—Dizziness—Memantine—Alzheimer's disease	9.46e-05	0.000514	CcSEcCtD
Carvedilol—Nausea—Donepezil—Alzheimer's disease	9.36e-05	0.000509	CcSEcCtD
Carvedilol—Dizziness—Rivastigmine—Alzheimer's disease	9.25e-05	0.000503	CcSEcCtD
Carvedilol—Vomiting—Memantine—Alzheimer's disease	9.1e-05	0.000494	CcSEcCtD
Carvedilol—Rash—Memantine—Alzheimer's disease	9.02e-05	0.00049	CcSEcCtD
Carvedilol—Dermatitis—Memantine—Alzheimer's disease	9.01e-05	0.00049	CcSEcCtD
Carvedilol—Headache—Memantine—Alzheimer's disease	8.96e-05	0.000487	CcSEcCtD
Carvedilol—Vomiting—Rivastigmine—Alzheimer's disease	8.9e-05	0.000484	CcSEcCtD
Carvedilol—Rash—Rivastigmine—Alzheimer's disease	8.82e-05	0.00048	CcSEcCtD
Carvedilol—Dermatitis—Rivastigmine—Alzheimer's disease	8.82e-05	0.000479	CcSEcCtD
Carvedilol—Headache—Rivastigmine—Alzheimer's disease	8.77e-05	0.000476	CcSEcCtD
Carvedilol—Nausea—Memantine—Alzheimer's disease	8.5e-05	0.000462	CcSEcCtD
Carvedilol—Nausea—Rivastigmine—Alzheimer's disease	8.31e-05	0.000452	CcSEcCtD
Carvedilol—ABCB1—brain—Alzheimer's disease	7.75e-05	0.00117	CbGeAlD
Carvedilol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	2.35e-06	1.8e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NOTCH1—Alzheimer's disease	2.35e-06	1.8e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CREB1—Alzheimer's disease	2.34e-06	1.8e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NGF—Alzheimer's disease	2.33e-06	1.79e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	2.33e-06	1.79e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—INS—Alzheimer's disease	2.33e-06	1.79e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NOTCH1—Alzheimer's disease	2.31e-06	1.77e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	2.31e-06	1.77e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	2.31e-06	1.77e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.31e-06	1.77e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	2.3e-06	1.76e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	2.3e-06	1.76e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TGFB1—Alzheimer's disease	2.29e-06	1.76e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCL2—Alzheimer's disease	2.29e-06	1.76e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TGFB1—Alzheimer's disease	2.29e-06	1.76e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—NOS3—Alzheimer's disease	2.28e-06	1.75e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CALM1—Alzheimer's disease	2.28e-06	1.75e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—NOS3—Alzheimer's disease	2.27e-06	1.75e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	2.27e-06	1.74e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	2.27e-06	1.74e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—APOE—Alzheimer's disease	2.27e-06	1.74e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—BCHE—Alzheimer's disease	2.27e-06	1.74e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NOS3—Alzheimer's disease	2.26e-06	1.74e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	2.26e-06	1.74e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	2.25e-06	1.73e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CAV1—Alzheimer's disease	2.25e-06	1.73e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.24e-06	1.72e-05	CbGpPWpGaD
Carvedilol—XDH—Metabolism—AKT1—Alzheimer's disease	2.23e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	2.23e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.23e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	2.22e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	2.22e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	2.22e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	2.22e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	2.2e-06	1.69e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—GSK3B—Alzheimer's disease	2.2e-06	1.69e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CREB1—Alzheimer's disease	2.18e-06	1.68e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—INS—Alzheimer's disease	2.17e-06	1.67e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	2.17e-06	1.66e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PPARG—Alzheimer's disease	2.15e-06	1.65e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	2.15e-06	1.65e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CALM1—Alzheimer's disease	2.15e-06	1.65e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	2.14e-06	1.64e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—APOE—Alzheimer's disease	2.14e-06	1.64e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	2.14e-06	1.64e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCL2—Alzheimer's disease	2.14e-06	1.64e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	2.12e-06	1.63e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CAV1—Alzheimer's disease	2.12e-06	1.63e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—INS—Alzheimer's disease	2.11e-06	1.62e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	2.11e-06	1.62e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	2.1e-06	1.62e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IGF1—Alzheimer's disease	2.1e-06	1.61e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	2.1e-06	1.61e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	2.1e-06	1.61e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.1e-06	1.61e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	2.1e-06	1.61e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	2.09e-06	1.61e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTGS2—Alzheimer's disease	2.08e-06	1.6e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	2.08e-06	1.6e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTGS2—Alzheimer's disease	2.08e-06	1.6e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	2.07e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	2.07e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	2.07e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	2.07e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	2.07e-06	1.59e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	2.06e-06	1.58e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.05e-06	1.58e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	2.05e-06	1.57e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	2.04e-06	1.57e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—LPL—Alzheimer's disease	2.04e-06	1.57e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	2.01e-06	1.55e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.01e-06	1.54e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.98e-06	1.52e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PPARG—Alzheimer's disease	1.98e-06	1.52e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	1.97e-06	1.51e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	1.95e-06	1.5e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—INS—Alzheimer's disease	1.94e-06	1.49e-05	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—AKT1—Alzheimer's disease	1.94e-06	1.49e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	1.92e-06	1.48e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—LPL—Alzheimer's disease	1.92e-06	1.47e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CASP3—Alzheimer's disease	1.92e-06	1.47e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	1.91e-06	1.47e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	1.91e-06	1.46e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL6—Alzheimer's disease	1.91e-06	1.46e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NOS3—Alzheimer's disease	1.9e-06	1.46e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—LPL—Alzheimer's disease	1.9e-06	1.46e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	1.9e-06	1.46e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TP53—Alzheimer's disease	1.89e-06	1.45e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TP53—Alzheimer's disease	1.88e-06	1.45e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.88e-06	1.45e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.88e-06	1.45e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	1.87e-06	1.44e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	1.87e-06	1.44e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PPARG—Alzheimer's disease	1.86e-06	1.43e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—NOS3—Alzheimer's disease	1.85e-06	1.42e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.85e-06	1.42e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	1.84e-06	1.41e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.83e-06	1.41e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—INS—Alzheimer's disease	1.83e-06	1.4e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.79e-06	1.37e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	1.79e-06	1.37e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	1.78e-06	1.37e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	1.77e-06	1.36e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	1.76e-06	1.36e-05	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.76e-06	1.35e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MAPK8—Alzheimer's disease	1.76e-06	1.35e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—AKT1—Alzheimer's disease	1.76e-06	1.35e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.75e-06	1.34e-05	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.75e-06	1.34e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	1.75e-06	1.34e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	1.74e-06	1.33e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	1.74e-06	1.33e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	1.73e-06	1.33e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.73e-06	1.33e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—Alzheimer's disease	1.73e-06	1.33e-05	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.73e-06	1.33e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—Alzheimer's disease	1.72e-06	1.32e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	1.72e-06	1.32e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.71e-06	1.32e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.71e-06	1.32e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	1.71e-06	1.31e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOE—Alzheimer's disease	1.71e-06	1.31e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	1.71e-06	1.31e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NOS3—Alzheimer's disease	1.7e-06	1.31e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	1.7e-06	1.3e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	1.69e-06	1.3e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.69e-06	1.3e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.67e-06	1.28e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.65e-06	1.27e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.63e-06	1.25e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—VEGFA—Alzheimer's disease	1.63e-06	1.25e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—LPL—Alzheimer's disease	1.63e-06	1.25e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	1.62e-06	1.24e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.62e-06	1.24e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.61e-06	1.24e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	1.61e-06	1.23e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.61e-06	1.23e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	1.61e-06	1.23e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NOS3—Alzheimer's disease	1.6e-06	1.23e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	1.6e-06	1.23e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.6e-06	1.23e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.6e-06	1.23e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.6e-06	1.23e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.59e-06	1.22e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—AKT1—Alzheimer's disease	1.59e-06	1.22e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	1.59e-06	1.22e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.59e-06	1.22e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—AKT1—Alzheimer's disease	1.59e-06	1.22e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.59e-06	1.22e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	1.58e-06	1.21e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.58e-06	1.21e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	1.57e-06	1.21e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	1.57e-06	1.2e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	1.55e-06	1.19e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.55e-06	1.19e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.49e-06	1.15e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.49e-06	1.14e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.49e-06	1.14e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	1.48e-06	1.14e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.48e-06	1.14e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.47e-06	1.13e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	1.47e-06	1.13e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	1.46e-06	1.13e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.46e-06	1.12e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—INS—Alzheimer's disease	1.46e-06	1.12e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.46e-06	1.12e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	1.45e-06	1.11e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.43e-06	1.1e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.41e-06	1.09e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.4e-06	1.08e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.4e-06	1.08e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.39e-06	1.07e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.38e-06	1.06e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—INS—Alzheimer's disease	1.37e-06	1.06e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.37e-06	1.05e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.37e-06	1.05e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CALM1—Alzheimer's disease	1.37e-06	1.05e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.36e-06	1.05e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—INS—Alzheimer's disease	1.36e-06	1.05e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	1.36e-06	1.05e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.35e-06	1.04e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.35e-06	1.04e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.35e-06	1.04e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	1.33e-06	1.02e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.33e-06	1.02e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.31e-06	1.01e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.31e-06	1e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.3e-06	9.98e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.3e-06	9.95e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.28e-06	9.83e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.26e-06	9.68e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.26e-06	9.64e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.24e-06	9.52e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TP53—Alzheimer's disease	1.23e-06	9.45e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.21e-06	9.27e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.21e-06	9.26e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.2e-06	9.25e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.2e-06	9.22e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.2e-06	9.18e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.19e-06	9.12e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.17e-06	8.99e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—INS—Alzheimer's disease	1.16e-06	8.95e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.13e-06	8.68e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—Alzheimer's disease	1.13e-06	8.65e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	1.12e-06	8.61e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.11e-06	8.56e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.11e-06	8.53e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.1e-06	8.47e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.1e-06	8.46e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	1.1e-06	8.42e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.09e-06	8.4e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.06e-06	8.11e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.05e-06	8.08e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—AKT1—Alzheimer's disease	1.05e-06	8.04e-06	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—AKT1—Alzheimer's disease	1.05e-06	8.03e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.04e-06	8.01e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—AKT1—Alzheimer's disease	1.04e-06	7.98e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	1.04e-06	7.97e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	1.03e-06	7.88e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.02e-06	7.86e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.02e-06	7.85e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.02e-06	7.84e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	7.81e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	1e-06	7.71e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	9.49e-07	7.29e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	9.46e-07	7.27e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	9.37e-07	7.2e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	9.34e-07	7.18e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	9.34e-07	7.18e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	9.25e-07	7.11e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARG—Alzheimer's disease	9.17e-07	7.04e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	9.06e-07	6.96e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—INS—Alzheimer's disease	8.99e-07	6.91e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	8.76e-07	6.73e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	8.62e-07	6.62e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AKT1—Alzheimer's disease	8.51e-07	6.53e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	8.42e-07	6.47e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	8.3e-07	6.37e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.88e-07	6.06e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AKT1—Alzheimer's disease	7.81e-07	6e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	7.71e-07	5.92e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	7.65e-07	5.88e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AKT1—Alzheimer's disease	7.36e-07	5.66e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	7.21e-07	5.54e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	7.11e-07	5.46e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AKT1—Alzheimer's disease	5.88e-07	4.52e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AKT1—Alzheimer's disease	5.54e-07	4.26e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AKT1—Alzheimer's disease	5.49e-07	4.22e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AKT1—Alzheimer's disease	4.7e-07	3.61e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.62e-07	2.78e-06	CbGpPWpGaD
